SCHEMBL10746124

SCHEMBL10746124

COc1ccc(C2CNCCc3cc(OC)c(SC)cc32)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD1 P21728 8/20 0.57
DRD5 P21918 6/20 0.57
ADCY5 O95622 2/20 0.47
HTR2C P28335 9/20 0.47
HTR2A P28223 9/20 0.45
HTR2B P41595 8/20 0.45
KDM4E B2RXH2 3/20 0.43
MAPT P10636 2/20 0.43
DRD2 P14416 2/20 0.43
HPGD P15428 2/20 0.43
ADCY6 O43306 1/20 0.43
ADCY3 O60266 1/20 0.43
ADCY9 O60503 1/20 0.43
ADCY8 P40145 1/20 0.43
ADCY7 P51828 1/20 0.43
ADCY2 Q08462 1/20 0.43
ADCY1 Q08828 1/20 0.43
ADCY4 Q8NFM4 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10747041 0.89 DRD1 (0.71) DRD1DRD5ADCY5KDM4EMAPT
Hydrochloric Acid SCHEMBL10745663 0.88 DRD1 (0.69) DRD1DRD5ADCY5KDM4EMAPT
SCHEMBL10748210 0.85 DRD1 (0.67) DRD1DRD5ADCY5HTR2AKDM4E
Hydrochloric Acid SCHEMBL10744987 0.84 DRD1 (0.66) DRD1DRD5ADCY5HTR2AKDM4E
SCHEMBL10345635 0.83 HTR2C (0.64) DRD1DRD5ADCY5HTR2CHTR2A
SCHEMBL10345668 0.83 DRD1 (0.57) DRD1DRD5ADCY5KDM4EMAPT
SCHEMBL11609656 0.82 DRD1 (0.60) DRD1DRD5ADCY5HTR2CHTR2A
SCHEMBL10748260 0.82 DRD1 (0.57) DRD1DRD5ADCY5HTR2CHTR2A
SCHEMBL10747314 0.80 DRD1 (0.55) DRD1DRD5ADCY5HTR2CHTR2A
SCHEMBL7320752 0.76 DRD1 (0.81) DRD1DRD5ADCY5KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0244088-A2 1-Phenyl-3-benzazepine compounds and medicaments containing these compounds for treating gastrointestinal motility disorders SMITHKLINE BEECHAM CORPORATION (US) 1987-11-04 EP disclosed